...
首页> 外文期刊>Gut and Liver >Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study
【24h】

Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study

机译:韩国肝硬化患者自发性细菌性腹膜炎的临床特征和预后:多中心回顾性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background/AimsAlthough early recognition and treatment with effective antibiotics have lead to improvements in the prognosis of patients with spontaneous bacterial peritonitis (SBP), it remains to be a serious complication in cirrhotic patients. This study was designed to evaluate the clinical manifestations and prognosis of patients with liver cirrhosis and SBP in Korea.MethodsThis was a multicenter retrospective study examining 157 episodes of SBP in 145 patients with cirrhosis. SBP was diagnosed based on a polymorphonuclear cell count in ascitic fluid of >250 cells/mm3 in the absence of data compatible with secondary peritonitis.ResultsThe mean age of the cohort was 56 years, and 121 (77%) of the 157 episodes of SBP occurred in men. Microorganisms were isolated in 66 episodes (42%): Gram-negative bacteria in 54 (81.8%), Gram-positive in 11 (16.7%), and Candida in 1. Isolated Gram-negative organisms were resistant to third-generation cephalosporin in 6 cases (17%), to ciprofloxacin in 11 (20.8%), and to penicillin in 33 (62.3%). The treatment failure and in-hospital mortality rates were 12.1% and 21%, respectively. A high Model of End-Stage Liver Disease (MELD) score, SBP caused by extended-spectrum β-lactamase-producing organisms, and hepatocellular carcinoma were independent prognostic factors of high in-hospital mortality.ConclusionsSBP remains to be a serious complication with high in-hospital mortality, especially in patients with a high MELD score.
机译:背景/目的尽管尽早识别和使用有效的抗生素治疗可改善自发性细菌性腹膜炎(SBP)患者的预后,但对于肝硬化患者而言,这仍然是严重的并发症。该研究旨在评估韩国肝硬化和SBP患者的临床表现和预后。方法这是一项多中心回顾性研究,检查了145例肝硬化患者的SBP 157发作。在缺乏与继发性腹膜炎相容性数据的情况下,根据腹水中多形核细胞计数> 250细胞/ mm3来诊断为SBP。结果该人群的平均年龄为56岁,在157次SBP发作中为121岁(77%)发生在男人身上。分离出的微生物有66次(42%):革兰氏阴性菌54例(81.8%),革兰氏阳性菌11例(16.7%)和念珠菌1例。分离出的革兰氏阴性菌对第三代头孢菌素有抗药性。 6例(17%),环丙沙星11例(20.8%),青霉素33例(62.3%)。治疗失败率和住院死亡率分别为12.1%和21%。终末期肝病(MELD)评分高,由产生广谱β-内酰胺酶的生物引起的SBP和肝细胞癌是高院内死亡率的独立预后因素。结论SBP仍然是高死亡率的严重并发症。住院死亡率,尤其是MELD评分高的患者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号